Medical articles today

/* 728x15, */

Mental Health 'Bible' Starts Revamp With New Terminology, Diagnoses

The Wall Street Journal: "Mental-health experts wrestling with how to fit temper tantrums, hoarding and even Internet addiction into the current understanding of mental illness are proposing changes to the field's primary reference for diagnoses for the first time in 16 years. The draft revisions of the Diagnostic and Statistical Manual of Mental Disorders - the bible for mental health clinicians and researchers - unveiled Wednesday could have effects that ripple through mental health care." Researchers, clinicians and insurance companies use the DSM to make diagnostic, treatment and coverage decisions. For drug companies, changes could open up opportunities for new drugs or expand the uses of existing ones" (Wang, 2/10).

Diet Drug Implicated In Depression And Suicidality

A group of claimants who were prescribed the diet drug Acomplia (Rimonabant) are bringing proceedings against the manufacturer, Sanofi Aventis, for compensation for depression and suicidal ideation suffered as a result of taking the drug. Acomplia was withdrawn from the European market in December 2008, following findings that the drug doubled the risk of patients suffering from depression and other psychiatric disorders compared with patients taking a placebo. If you have suffered similar side effects from Acomplia, and would like information on joining the group action against Sanofi Aventis, please email Bozena Michalowska-Howells at Leigh Day & Co solicitors.

/* 468x60, */

Seaside Therapeutics Announces Issuance Of Key Patent For Treatment Of Autism Spectrum Disorders

Seaside Therapeutics LLC announced the issuance of U.S. patent 7, 648, 993 B2 ('993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6, 890, 931 B2 ('931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway. Related patents have also issued in Europe (EP 1 392 363 B1) and have been allowed in Canada. Together, these patents form the foundation of Seaside's intellectual property estate. The method of use claims in these patents reflect critical observations of the mGluR pathway and its implications in the causation of Fragile X Syndrome, autism and other disorders of brain development.

Many Veterans Not Getting Enough Treatment For PTSD

Although the Department of Veteran Affairs is rolling out treatments nationwide as fast as possible to adequately provide for newly diagnosed PTSD patients, there are still significant barriers to veterans getting a full course of PTSD treatment. The study is published in the latest issue of the Journal of Traumatic Stress. More than 230, 000 Iraq and Afghanistan war veterans sought treatment for the first time at VA healthcare facilities nationwide between 2002 and 2008. More than 20 percent of these veterans, almost 50, 000, received a new PTSD diagnosis. Treatments that have been shown to be effective for PTSD typically require 10-12 weekly sessions.

Cultures Of Suicide Studied By University Of Queensland Researcher, Australia

A UQ researcher has surveyed and interviewed students across three continents to understand the social representations, values, beliefs, attitudes and meanings associated with youth suicide. PhD graduate Dr Erminia Colucci surveyed almost 700 students aged 18-24 in Italy, India and Australia, revealing several differences and similarities across cultures in regards to meanings and social representations of suicide. "First, there were differences in prevalence with more Italian and Australian youths indicating they think about suicide, compared to Indians, " she said. "In contrast, Indians reported more suicide attempts, followed by Australians and then Italians.

/* 468x60, */

What Is Obsessive Compulsive Disorder OCD ?

Obsessive-compulsive disorder (OCD) is a type of anxiety disorder. It causes obsessive thoughts and fears that lead to engage in compulsive behavior. It is a chronic mental health condition. A person suffering from obsessive-compulsive disorder may realize that their obsessions are not reasonable, and may try to ignore them or stop them. But that only increases distress and anxiety. Ultimately, the person feels driven to perform compulsive acts in an effort to ease their distress. The intrusive thoughts produce anxiety. The repetitive behaviors are aimed at reducing anxiety. According to Medilexicon's medical dictionary, obsessive-compulsive disorder (OCD) is: a type of anxiety disorder the essential features of which include recurrent obsessions, persistent intrusive ideas, thoughts, impulses or images, or compulsions (repetitive, purposeful, and intentional behaviors performed to decrease anxiety in response to an obsession) sufficiently severe to cause marked distress, be time-consuming, or significantly interfere with the person's normal routine, occupational functioning, or usual social activities or relationships with others.

Rocket: [100]
/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy